Standard Treatment with Alteplase to Reverse Stroke study "STARS"

Completed

Phase N/A Results

Summary of Purpose

To assess the safety, clinical outcome, and adverse events in patients treated with intravenous tPA for acute stroke.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 25 January 2001.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Trial Design

Prospective, multicenter study of 389 patients at 57 medical centers in the United States.

Contacts

  • GW Albers, Stanford Stroke Center, Stanford University Medical Center, Palo Alto, California 94304-1705, USA.

    albers@leland.stanford.edu